:

Xintai Fan1, Ziwen Gao1, Jiake Zhong2

  • 1ENT Institute and Department of Otorhinolaryngology, Eye & ENT Hospital, Fudan University, Shanghai, China; Shanghai Key Laboratory of Gene Editing and Cell Therapy for Rare Diseases, Fudan University, Shanghai, China; NHC Key Laboratory of Hearing Medicine, Shanghai, China.

Med (New York, N.Y.)
|October 24, 2025
PubMed
概括

这项研究为遗传性听力损失的基因疗法建立了第一个国际共识,为临床试验和患者护理创造了标准化的框架. 这些指导方针旨在加速研究翻译,并确保新兴治疗方法的安全性.